You are here
Mortality in pharmacologically treated older adults with diabetes: the Cardiovascular Health Study, 1989-2001.
Tuesday,2012-11-06 12:07 America/Los_Angeles — eenright
| Title | Mortality in pharmacologically treated older adults with diabetes: the Cardiovascular Health Study, 1989-2001. |
| Publication Type | Journal Article |
| Year of Publication | 2006 |
| Authors | Kronmal, RA, Barzilay, JI, Smith, NL, Psaty, BM, Kuller, LH, Burke, GL, Furberg, C |
| Journal | PLoS Med |
| Volume | 3 |
| Issue | 10 |
| Pagination | e400 |
| Date Published | 2006 Oct |
| ISSN | 1549-1676 |
| Keywords | Administration, Oral, Aged, Cardiovascular Diseases, Coronary Disease, Diabetes Mellitus, Female, Humans, Hypoglycemic Agents, Insulin, Male, Proportional Hazards Models, Prospective Studies, Risk Assessment, Sex Distribution |
| Abstract | <p><b>BACKGROUND: </b>Diabetes mellitus (DM) confers an increased risk of mortality in young and middle-aged individuals and in women. It is uncertain, however, whether excess DM mortality continues beyond age 75 years, is related to type of hypoglycemic therapy, and whether women continue to be disproportionately affected by DM into older age.</p><p><b>METHODS AND FINDINGS: </b>From the Cardiovascular Health Study, a prospective study of 5,888 adults, we examined 5,372 participants aged 65 y or above without DM (91.2%), 322 with DM treated with oral hypoglycemic agents (OHGAs) (5.5%), and 194 with DM treated with insulin (3.3%). Participants were followed (1989-2001) for total, cardiovascular disease (CVD), coronary heart disease (CHD), and non-CVD/noncancer mortality. Compared with non-DM participants, those treated with OHGAs or insulin had adjusted hazard ratios (HRs) for total mortality of 1.33 (95% confidence interval [CI], 1.10 to 1.62) and 2.04 (95% CI, 1.62 to 2.57); CVD mortality, 1.99 (95% CI, 1.54 to 2.57) and 2.16 (95% CI, 1.54 to 3.03); CHD mortality, 2.47 (95% CI, 1.89 to 3.24) and 2.75 (95% CI, 1.95 to 3.87); and infectious and renal mortality, 1.35 (95% CI, 0.70 to 2.59) and 6.55 (95% CI, 4.18 to 10.26), respectively. The interaction of age (65-74 y versus > or =75 y) with DM was not significant. Women treated with OHGAs had a similar HR for total mortality to men, but a higher HR when treated with insulin.</p><p><b>CONCLUSIONS: </b>DM mortality risk remains high among older adults in the current era of medical care. Mortality risk and type of mortality differ between OHGA and insulin treatment. Women treated with insulin therapy have an especially high mortality risk. Given the high absolute CVD mortality in older people, those with DM warrant aggressive CVD risk factor reduction.</p> |
| DOI | 10.1371/journal.pmed.0030400 |
| Alternate Journal | PLoS Med |
| PubMed ID | 17048978 |
| PubMed Central ID | PMC1609124 |
| Grant List | N01 HC015103 / HC / NHLBI NIH HHS / United States N01-HC-85086 / HC / NHLBI NIH HHS / United States N01HC85086 / HL / NHLBI NIH HHS / United States N01-HC-85079 / HC / NHLBI NIH HHS / United States N01HC85079 / HL / NHLBI NIH HHS / United States N01 HC035129 / HC / NHLBI NIH HHS / United States |